Cite
HARVARD Citation
Jone, P. et al. (2018). Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions. Pediatric infectious disease journal. 37 (10), p. . [Online].